Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonMark Ainsworth, Christopher J. Groves, Amy Beveridge et al.|The Lancet Infectious Diseases|2020Cited by 405
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Helen Fryer, Koen B. Pouwels et al.|Nature Medicine|2022Cited by 268
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, David Bonsall, Philippa C. Matthews et al.|Nature Communications|2021Cited by 147